Quentis Therapeutics (Biotechnology, Health Care) — Funding, Investors & Signals 2026

Quentis Therapeutics

Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer

Founded 2016 Grant Total: $49.00M Biotechnology, Health Care +1

Quentis Therapeutics is a biotechnology startup founded in 2016 that is focused on developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer. The company's slogan, "Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer," reflects its commitment to addressing ER stress across various diseases. Quentis Therapeutics' latest funding, a $1.00M grant investment, was received on 03 December 2018 from the New York City Economic Development Corporation (NYCEDC). This investment signifies the recognition and support of Quentis Therapeutics' efforts to enhance the immune system's capacity to combat cancer, thereby providing patients with advanced cancer treatment options. The company operates within the industries of Biotechnology, Health Care, and Health and Wellness. Although the headquarters location is not specified, Quentis Therapeutics' focus on revolutionary immuno-therapies positions it as an innovative player in the biotechnology sector with significant potential for impact and growth.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$1.00M	1		03 Dec 2018
Series A	$48.00M	7	New York Ventures, Taiho Pharmaceutical Co	27 Feb 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$1.00M

03 Dec 2018

Series A

$48.00M

New York Ventures, Taiho Pharmaceutical Co

27 Feb 2018

FAQ About Quentis Therapeutics

Developing innovative immuno-therapeutics to combat ER stress and empower the immune system in the fight against cancer

Quentis Therapeutics was founded in 2016.

Quentis Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.

Quentis Therapeutics has completed 2 funding rounds, raising a total of $49.00M. The latest funding stage is Grant.

Top alternatives and competitors to Quentis Therapeutics include FerroptoCure Inc., Pyrum Technologies India Pvt. Ltd., Ribon Therapeutics, S C Oncology, AbilityPharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Quentis Therapeutics and FerroptoCure Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Quentis Therapeutics

General Information

Track Quentis Therapeutics

Discover More

About Quentis Therapeutics

Funding Rounds & Investors (2)

Quentis Therapeutics Alternatives & Competitors

FAQ About Quentis Therapeutics

Don't just browse. Track.